Oklahoma 2023 2023 Regular Session

Oklahoma House Bill HB2686 Amended / Bill

Filed 03/05/2023

                     
 
HB2686 HFLR 	Page 1 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
HOUSE OF REPRESENTATIVES - FLOOR VERSION 
 
STATE OF OKLAHOMA 
 
1st Session of the 59th Legislature (2023) 
 
COMMITTEE SUBSTITUTE 
FOR 
HOUSE BILL NO. 2686 	By: West (Rick) and Waldron 
 
 
 
 
 
COMMITTEE SUBSTITUTE 
 
An Act relating to mental health; amending 43a O.S. 
2021, Section 3-601, which relates to opioid 
substitution treatment programs and addicted persons ; 
mandating drug screens; and providing an effective 
date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLA HOMA: 
SECTION 1.     AMENDATORY     43a O.S. 2021 , Section 3-601, is 
amended to read as follows: 
Section 3-601. A.  Any Class II controlled dangerous substance, 
when used in this state by an opioid substitution treatment program 
for persons with a history of opioid addiction to or physiologic 
dependence on controlled dangerous substances, shall only be used: 
1.  In treating pers ons with a history of addiction ; 
2.  In treating persons with a one -year history of opioid 
addiction to or physiolog ic dependence on control led dangerous   
 
HB2686 HFLR 	Page 2 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
substances, as defined by the Code of Federal Regulations, and 
documentation of attempting another type of treatment; or 
3.  If clinically appro priate, the program physician may waive 
the requirement of a one -year history of opioid addiction for 
consumers within six (6) months of release from a penal institution, 
for consumers with a pregnancy verified by the program physician, or 
for consumers having previously received treatment for opioid 
addiction and within two (2) years of discharge from that treatment 
episode. 
Provided, however, that persons who are participating in the 
opioid substitution treatment prog ram, pursuant to this subsection, 
shall be administered a minimum of eight (8) random , witnessed, 
urine drug screens annually. 
B.  Any conviction for a violation of the provis ions of this 
section or any rules promulgated pursuant to the provisions of this 
section shall be a felony. 
C.  For the purposes of this section, "opioid substitution 
treatment program" means a person, private physician , or 
organization that administers or dispenses an opioid drug to a 
narcotic addict for the purposes of detoxification or maintenance 
treatment or provides, when necessary and appropriate, comprehensive 
medical and rehabilitation services.  A private physi cian who 
administers buprenorphine wi th a waiver from the Drug Enforcement 
Administration shall not be considered an o pioid substitution   
 
HB2686 HFLR 	Page 3 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
treatment program.  An opioid substitution treatment program shall 
be certified by the Board of Mental Health and Subst ance Abuse 
Services, or the Commissio ner of Mental Health and Substance Abuse 
Services upon delegation by the Board, a nd registered with the 
federal Drug Enforcement Administration for the use of an opioid 
drug to treat narcotic addiction. 
D.  The Board of Mental Health and Substance Abuse Se rvices 
shall promulgate rules and standards for the certification of all 
programs, private facilities, and organization s which provide opioid 
substitution treatment directed to those physiologically dependent 
on or addicted to opioids.  These facilities an d organizations shall 
be known as "Opioid Substitution Treatment Programs ".  Only 
certified facilities may receive and assist opioid-dependent and 
addicted persons by providing Class II controlled substances in 
opioid substitution treatment and rehabilitat ion. 
E.  The Board of Mental Health and Substance Abuse Services 
shall promulgate rules and standards regulating the tr eatment and 
services provided by opioid substitution treatment p rograms.  
Failure to comply with rul es and standards promulgated by the B oard 
shall be grounds for revocation, suspension or nonrenewal of 
certification. 
F. Opioid substitution treatment prog rams shall notify the 
Department of Mental Health and Substance Abuse Services of plans to   
 
HB2686 HFLR 	Page 4 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
close or relocate within a minimum of thirty ( 30) days prior to 
closure or relocation. 
G.  Failure to comply with rules and sta ndards promulgated by 
the Board of Mental Health and Substance Abuse Services pursuant to 
this section shall be grounds for reprimand, sus pension, revocation 
or nonrenewal of certification. 
SECTION 2.  This act shall become effective November 1, 2023. 
 
COMMITTEE REPORT BY: COMMITTEE ON ALCOHOL, TOBACCO AND CONTROLLED 
SUBSTANCES, dated 03/02/2023 - DO PASS, As Amended and Coau thored.